Shape‐Regulated Photothermal‐Catalytic Tumor Therapy Using Polydopamine@Pt Nanozymes with the Elicitation of an Immune Response
Small · 2024-05 · 20 (20)
DOI: 10.1002/smll.202309096 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 06.12.2023. Verfasst von Zhilong Xu und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Chemical Engineering, Yangzhou University, Yangzhou, Jiangsu, 225002, P. R. China. Hauptthemen laut MEDLINE: Indoles, Polymers, Platinum. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province, Priority Academic Program Development of Jiangsu Higher Education Institutions.
Abstract (Originalsprache)
Recently, nanozyme‐based photothermal‐catalytic therapy has emerged as a promising strategy for antitumor treatment. Extensive research has focused on optimizing the catalytic activity and photothermal conversion performance of nanozymes through size, morphology, and surface property regulations. However, the biological effects of nanozymes, such as cellular uptake and cytotoxicity, resulting from their physicochemical properties, remain largely unexplored. In this study, two types of polydopamine/platinum (PDA@Pt) nanozymes, flower‐like (FPDA@Pt) and mesoporous spherical‐like (MPDA@Pt), to comprehensively compare their enzyme‐mimicking activity, photothermal conversion capacity, and antitumor efficiency are designed. These findings revealed that FPDA@Pt exhibited superior peroxidase‐like activity and higher photothermal conversion efficiency compared to MPDA@Pt. This led to enhanced production of reactive oxygen species (ROS) and increased heat generation at tumor sites. Importantly, it is observed thatthe flower‐like structure of FPDA@Pt facilitated enhanced cellular uptake, leading to an increased accumulation of nanozymes within tumor cells. Furthermore, the light irradiation on tumors also triggered a series of anti‐tumor immune responses, further enhancing the therapeutic efficacy. This work provides a possible design orientation for nanozyme‐based photothermal‐catalytic tumor therapy, highlighting the importance of considering the physicochemical properties of nanozymes to optimize their therapeutic potential in antitumor strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemistry and Chemical Engineering, Yangzhou University, Yangzhou, Jiangsu, 225002, P. R. China.
- Institute of Translational Medicine, Department of Pharmacology, School of Medicine, Yangzhou University, Yangzhou, Jiangsu, 225002, P. R. China.
- Central LAB, Binhai County People's Hospital, Binhai, Jiangsu, 224500, P. R. China.
- School of Chemical Engineering, Yangzhou Polytechnic Institute, Yangzhou, Jiangsu, 225127, P. R. China.
- Jiangsu Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment of Senile Diseases, Yangzhou, Jiangsu, 225009, P. R. China.
ORCID-Profile: Lei Fan
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province
- Priority Academic Program Development of Jiangsu Higher Education Institutions
Zitieren
APA
Xu, Z., Jiang, J., Li, Y., Hu, T., Gu, J., Zhang, P., Fan, L., Xi, J., Han, J., & Guo, R. (2024). Shape‐Regulated Photothermal‐Catalytic Tumor Therapy Using Polydopamine@Pt Nanozymes with the Elicitation of an Immune Response. Small, 20(20). https://doi.org/10.1002/smll.202309096
Vancouver
Xu Z, Jiang J, Li Y, Hu T, Gu J, Zhang P, et al. Shape‐Regulated Photothermal‐Catalytic Tumor Therapy Using Polydopamine@Pt Nanozymes with the Elicitation of an Immune Response. Small. 2024;20(20). doi:10.1002/smll.202309096
BibTeX
@article{Xu2024,
author = {Xu, Zhilong and Jiang, Jian and Li, Yanan and Hu, Ting and Gu, Jiake and Zhang, Peiying and Fan, Lei and Xi, Juqun and Han, Jie and Guo, Rong},
title = {Shape‐Regulated Photothermal‐Catalytic Tumor Therapy Using Polydopamine@Pt Nanozymes with the Elicitation of an Immune Response},
journal = {Small},
year = {2024},
volume = {20},
number = {20},
doi = {10.1002/smll.202309096}
}
EUVIMED